US$ 22.87
glp-1 drugs venom New obesity drug semaglutide is safe and effective for weight loss and diabetes Monotreme glucagon-like peptide-1 in venom
Description
Risk of bias: all four RCTs were rated low risk by RoB2 (with some concerns for open-label outcome ascertainment in three trials, a domain-specific issue that does not alter the overall RoB2 category from low)

Five scientists won this years Breakthrough Prize in Life Sciences for their work on GLP-1 and the development of drugs for diabetes and obesity.
NOC= Notice of Compliance.

In a 6-week randomized phase 1 trial, tirzepatide led to reduced caloric intake during a meal test at week 3 compared with placebo and liraglutide in people with overweight or obesity.

Im also hearing about people doing Ozempic microdosing
